Effect of azidothymidine (AZT) on HIV P24 antigen, beta2-microglobulin, neopterin, soluble CD8, soluble interleukin-2 receptor and tumor necrosis factor alpha levels in patients with AIDS-related complex or AIDS
- 1 January 1990
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 12 (7) , 737-741
- https://doi.org/10.1016/0192-0561(90)90036-m
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Serum 2-Microglobulin Decreases in Patients with AIDS or ARC Treated with AzidothymidineThe Journal of Infectious Diseases, 1989
- Survival Experience Among Patients With AIDS Receiving ZidovudinePublished by American Medical Association (AMA) ,1988
- HIV Therapeutics: An Emerging SciencePublished by American Medical Association (AMA) ,1988
- Predicting who will progress to AIDS.BMJ, 1988
- Neopterin as a marker for activated cell-mediated immunity: Application in HIV infectionImmunology Today, 1988
- AzidothymidineThe Journal of Infectious Diseases, 1988
- The Human Immunodeficiency Virus: Infectivity and Mechanisms of PathogenesisScience, 1988
- Elevated Soluble Interleukin-2 Receptor Levels in Serum of Human Immunodeficiency Virus Infected PopulationsAIDS Research and Human Retroviruses, 1988
- Soluble interleukin 2 receptors are elevated in patients with AIDS or at risk of developing AIDSClinical Immunology and Immunopathology, 1987
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987